"Designing Growth Strategies is in our DNA"

Alzheimers Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonist, Combination Drugs, and Others), By Application (Disease Progression and Symptom Management), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy & Drug Stores, and Online Pharmacy), and Regional Forecast, 2023-2030

Last Updated: May 26, 2025 | Format: PDF | Report ID: FBI101033

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Alzheimer’s Disease, By Key Countries/Regions
    2. New Product Launches, By Key Players
    3. List of Approved Drugs
    4. Pipeline Analysis
    5. Key Industry Developments (Mergers, Acquisitions, Partnerships etc.)
    6. Recent Advances in Alzheimer's Research
    7. Impact of COVID-19 on the Market
  5. Global Alzheimer’s Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonist
      3. Combination Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Progression
      2. Symptom Management
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy & Drug Stores
      3. Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Alzheimer’s Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonist
      3. Combination Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Progression
      2. Symptom Management
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy & Drug Stores
      3. Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Alzheimer’s Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonist
      3. Combination Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Progression
      2. Symptom Management
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy & Drug Stores
      3. Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Rest of Europe
  8. Asia Pacific Alzheimer’s Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonist
      3. Combination Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Progression
      2. Symptom Management
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy & Drug Stores
      3. Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. China
      2. India
      3. Japan
      4. Australia
      5. Rest of Asia Pacific
  9. Rest of the World Alzheimer’s Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonist
      3. Combination Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Disease Progression
      2. Symptom Management
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy & Drug Stores
      3. Online Pharmacy
  10. Competitive Analysis
    1. Global Market Share Analysis (2022)
    2. Company Profiles
      1. EISAI CO., LTD.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Biogen Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. H. Lundbeck A/S
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Otsuka Pharmaceutical Co., Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1: Global Alzheimer’s Drugs Market Revenue Breakdown (USD billion, %) by Region, 2022 & 2030

Figure 2: Global Alzheimer’s Drugs Market Value Share (%), By Drug Class, 2022 & 2030

Figure 3: Global Alzheimer’s Drugs Market Value Share (%), By Application, 2022 & 2030

Figure 4: Global Alzheimer’s Drugs Market Value Share (%), By Distribution Channel, 2022 & 2030

Figure 5: Global Alzheimer’s Drugs Market Value (USD billion), by Region, 2022 & 2030

Figure 6: North America Alzheimer’s Drugs Market Value (USD billion), By Drug Class, 2022 & 2030

Figure 7: North America Alzheimer’s Drugs Market Value Share (%), By Drug Class, 2022

Figure 8: North America Alzheimer’s Drugs Market Value (USD billion), By Application, 2022 & 2030

Figure 9: North America Alzheimer’s Drugs Market Value Share (%), By Application, 2022

Figure 10: North America Alzheimer’s Drugs Market Value (USD billion), By Distribution Channel, 2022 & 2030

Figure 11: North America Alzheimer’s Drugs Market Value Share (%), By Distribution Channel, 2022

Figure 12: North America Alzheimer’s Drugs Market Value (USD billion), By Country, 2022 & 2030

Figure 13: North America Alzheimer’s Drugs Market Value Share (%), By Country, 2022

Figure 14: Europe Alzheimer’s Drugs Market Value (USD billion), By Drug Class, 2022 & 2030

Figure 15: Europe Alzheimer’s Drugs Market Value Share (%), By Drug Class, 2022

Figure 16: Europe Alzheimer’s Drugs Market Value (USD billion), By Application, 2022 & 2030

Figure 17: Europe Alzheimer’s Drugs Market Value Share (%), By Application, 2022

Figure 18: Europe Alzheimer’s Drugs Market Value (USD billion), By Distribution Channel, 2022 & 2030

Figure 19: Europe Alzheimer’s Drugs Market Value Share (%), By Distribution Channel, 2022

Figure 20: Europe Alzheimer’s Drugs Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 21: Europe Alzheimer’s Drugs Market Value Share (%), By Country/ Sub-region, 2022

Figure 22: Asia Pacific Alzheimer’s Drugs Market Value (USD billion), By Drug Class, 2022 & 2030

Figure 23: Asia Pacific Alzheimer’s Drugs Market Value Share (%), By Drug Class, 2022

Figure 24: Asia Pacific Alzheimer’s Drugs Market Value (USD billion), By Application, 2022 & 2030

Figure 25: Asia Pacific Alzheimer’s Drugs Market Value Share (%), By Application, 2022

Figure 26: Asia Pacific Alzheimer’s Drugs Market Value (USD billion), By Distribution Channel, 2022 & 2030

Figure 27: Asia Pacific Alzheimer’s Drugs Market Value Share (%), By Distribution Channel, 2022

Figure 28: Asia Pacific Alzheimer’s Drugs Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 29: Asia Pacific Alzheimer’s Drugs Market Value Share (%), By Country/ Sub-region, 2022

Figure 30: Rest of the World Alzheimer’s Drugs Market Value (USD billion), By Drug Class, 2022 & 2030

Figure 31: Rest of the World Alzheimer’s Drugs Market Value Share (%), By Drug Class, 2022

Figure 32: Rest of the World Alzheimer’s Drugs Market Value (USD billion), By Application, 2022 & 2030

Figure 33: Rest of the World Alzheimer’s Drugs Market Value Share (%), By Application, 2022

Figure 34: Rest of the World Alzheimer’s Drugs Market Value (USD billion), By Distribution Channel, 2022 & 2030

Figure 35: Rest of the World Alzheimer’s Drugs Market Value Share (%), By Distribution Channel, 2022

Figure 36: Global Alzheimer’s Drugs Market Share (%), By Company, 2022

Table 1: Global Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2019–2030

Table 2: Global Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 3: Global Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

Table 4: Global Alzheimer’s Drugs Market Revenue (USD billion) Forecast, by Region, 2019-2030

Table 5: North America Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2019-2030

Table 6: North America Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Application, 2019-2030

Table 7: North America Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2030

Table 8: North America Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Country, 2019-2030

Table 9: Europe Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2019-2030

Table 10: Europe Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Application, 2019-2030

Table 11: Europe Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2030

Table 12: Europe Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 13: Asia Pacific Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2019-2030

Table 14: Asia Pacific Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Application, 2019-2030

Table 15: Asia Pacific Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2030

Table 16: Asia Pacific Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 17: Rest of the World Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2019-2030

Table 18: Rest of the World Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Application, 2019-2030

Table 19: Rest of the World Alzheimer’s Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2030

Alzheimers Drugs Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 150
GET A FREE SAMPLE

    man icon
    Mail icon
    Captcha refresh
Consulting Services
    How will you benefit from our consulting services ?
OSZAR »